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Abstract
Microfluidic Gradient Device for Studying the Mesothelial Cells’ Migration and Effects of
Carbon Nanotubes Chronic Exposure
Hanyuan Zhang
Cell migration is one of the crucial steps in many human physiological events and
diseases, including cancers. Recent studies have shown that carbon nanotubes (CNTs), like
asbestos, can induce accelerated cell growth and invasiveness that contribute to their
mesothelioma pathogenicity. Malignant mesothelioma is a very aggressive tumor that develops
from cells of the mesothelium, and is most commonly caused by exposure to asbestos. CNTs
have similar structure and mode of exposure to asbestos. This has raised a particular concern
regarding the potential carcinogenicity of CNTs, especially in the pleural spaces, which are key
target tissues for asbestos-related diseases.
In this thesis, a passive diffusion based microfluidic device that generates stable gradient
is developed to study the migration of human lung mesothelial cells upon long-term exposure (4
months) to sub-cytotoxic concentration (0.02 µg/cm2) of single walled CNTs (SWCNTs). During
the migration, we observed that the cell morphology changed from a flattened shape to a spindleshape prior to the migration after the cell sensed the gradient. The migration of chronic SWCNTs
exposed mesothelial cells was conducted under different fetal bovine serum (FBS) concentration
gradients, and the velocities of cell migration and number of migrated cells were extracted and
compared. Results showed that chronic SWCNT exposed mesothelial cells were more aggressive
compared to non-CNTs treated cells with FBS concentration of 5% and 10% in terms of
migration velocity. The SWCNT exposed cells were less aggressive under the FBS concentration
of 15% and 20%. The method described here allows simultaneous detection of cell morphology
and migration under chemoattractant gradient conditions. It also allows for real time monitoring
of cell motility that resembles in vivo cell migration.
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Chapter 1. Cell Migration Review
1.1 What Are Cell Migration and Chemotaxis
Cell migration is a central process in the development and maintenance of multicellular
organisms. It refers to the phenomenon that cells will migrate in response to the soluble growth
factors in various biological processes such as embryonic morphogenesis, cancer metastasis,
tissue remodeling, wound healing, and inflammation [1,2,3,4]. Figure 1 shows an example of the
cancer metastasis. The migrating cells are highly polarized with complex regulatory pathways
that spatially and temporally integrate their component processes [5].

Figure 1. Schematic view of epithelial to mesenchymal transition (EMT) and metastasis [6]. A
tumor has a population of cells that have undergone EMT. These cells are now able to migrate
freely, by entering the circulatory system. Upon reaching their final destination, the cells undergo
the reverse MET program and form a secondary tumor at a distant site.
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Cell migration can be random or directed. The directed cell migration is also referred as
chemotaxis. Chemotaxis allows single cell or multicellular organism to find the environment that
provides them with greatest supply and flee from poisons.

1.2 Cell Migration Procedures
Cell migration involves a coordinated series of molecular and physical events. As shown
in Figure 2, generally, cells must acquire spatial asymmetry by polarization prior to their
migration. The polarization is trigged by extracellular gradient. The polarization will lead to a
series of morphological reactions, including reorganization of cytoskeleton to produce
polarization and cellular forces, membrane extension, formation and stabilization of cell
attachment, generation of contractile force and rear release. This process repeats as cells keep
migrating [5].

Figure 2. Cell migration procedures [7].
The migration process is driven by the protrusive force and the contractile force. The
protrusive force is provided by polymerization of actin filaments and structural organization
cross-linked with lattice or bundle [8,9]. The contractile force that leads the cell moving forward
is generated behind the cell front. The contractile force depends partly on active myosin activity
and involves separate mechanisms of force generation [10].
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1.3 Conventional Assays for Studying Cell Migration
Conventional assays and techniques for studying cell migration and chemotaxis include
Boyden chamber [11], Dunn chamber [12], Zigmond chamber [13], wound assay [14], Teflon
fence assay [15], agarose assay [16], electric cell-substrate impedance sensing migration (ECIS)
assay [17] and micropipette-based assay [18], as shown in Figure 3.
In Boyden chamber assay, two chambers are isolated by a porous membrane as a filter, as
shown in Figure 3 (A). The chambers are inserted into a single well of multiwall plates. Cells are
seeded on the porous membrane in the upper chamber and chemoattractant is loaded in the lower
chamber. Because cells will migrate across the membrane, the pore size of the membrane should
be properly chosen to enable active transmigration based on the size of cells. This assay is easy
to use and has the capability of studying chemotaxis and chemokinesis, screening multiple
compounds at different concentration [25].
The Dunn chamber is similar to the Zigmond chamber and it allows the behavior of cells
in the linear concentration gradient to be observed with a light microscope directly [12]. As
shown in Figure 3 (B), it consists of a glass cover slip with two concentric annular wells on a
glass slide. The depth of the annular wells are about half of the thickness of the glass slide. The
platform that separates the wells is called bridge. The height difference between the bridge and
the surface of the glass slide is about 20 µm. This gap allows cells to migrate in the space formed
by the bridge and the cover slip when a radially directed linear gradient is established by filling
the inner well with control media and the outer well with the media of chemoattractant [19].
Dunn chamber can provide good optical properties and a stable gradient.
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Figure 3. Conventional assays. (A) Schematic view of Boyden chamber. It consists of a chamber
with the cell media, a porous membrane and a large chamber with chemoattractant. (B) Dunn
chamber [19]. It consists of a glass cover slip and two concentric annular wells on a glass slide.
(C) Zigmond chamber [20]. It consists of two parallel channels and a glass bridge that are etched
into a glass slide. A cover slip is placed on top of the channels and bridge for cell seeding. (D)
Schematic view of wound healing process and adaption to multiple well plates [23]. It involves
4

the creation of a wound through a cell monolayer. The wound is healed by cell migration and
proliferation. To get a high throughput result, this method is often integrated with multiple well
plates. (a) Cell monolayer. (b) Creation of wound. (c) Cell migration to heal the wound. (d) 8500
well plate. (e) Producing wounds with consistent shape and position within each well with a 96
well pin array. (f) Images with 25 wells stained for filamentous actin. (E) Schematic drawing of
Teflon fence used for cell migration studies [15]. Cells are seeded in the center well formed by
Teflon fence. The fence is removed when a cell monolayer is formed. Cells are cultured
continuously for migration assessment. (F) Schematic view of agarose assay. Cells in small wells
or parallel channels can migrate in or under the semi-solidified agarose layer towards the higher
concentration of chemoattractant. (a) Agarose assay with small wells cut into agarose layer. (b)
Agarose assay with connected parallel channels cut into agarose layer. (G) Microfluidic device
integrated with cellular impedance sensing [21]. The substrate is electrode that carries weak
alternating current. Cell attachment and migration can cause electric impedance change, which is
recorded as a function of time. (a) Microfluidic device integrated with electrodes and circuits. (b)
Schematic illustration of electrode array. (c) Cross-section view of the sensor chip. (d) A local
enlarged photo of the electrode. (H) Micropipette-based assay [22]. Electrophysiology
micropipettes mounted in a micro controller that is positioned close to cells in a culture dish. The
micropipette is filled with chemoattractant and placed in the cell media. A precisely controlled
gradient can be formed by pneumatically ejecting the chemoattractant or letting the
chemoattractant passively diffuse from the micropipette tip to the cell media.
The Zigmond chamber is the first device that provides direct visualization of cell
behavior within a chemoattractant gradient. As shown in Figure 3 (C), it consists of two parallel
channels and a glass bridge. The parallel channels are etched into a glass slide, while the bridge
is below the surface of the glass slide. There is a gap (3 to 10 µm) between the cover slip and the
bridge, where cells seeded on the cover slip can migrate through the bridge when a gradient is
established by filling one channel with chemoattractant media and the other channel with control
media.
Wound assay involves the creation of a wound gap by scratching through a cell
monolayer. The wound gap causes the disruption of cell-cell contacts and increases the
concentrations of the growth factors at the wound margin. Cell monolayer will try to heal the
wound by proliferation and migration, as shown in Figure 3 (D) [14]. The wound heals in a
stereotyped fashion – cells polarize toward the wound, initiate protrusion, migrate, and close the
wound [23]. By taking images with a constant time interval, cell migration and cell proliferation
5

at different time can be observed and compared. Nowadays, the wound assay is often adapted to
a multiple well plates to achieve a high throughput result. After seeding cells in a multiple well
plates, characteristically sized wounds are created at each well by a pin array. Though wound
assay should not be considered as a duplicate of cell migration in vivo, it is suitable for studying
effects of ECM and other cells’ migration in a simple and inexpensive way [24].
Teflon fence assay is the technology to confine cells in circular region within a Teflon
fence, which is fitted in a culture dish. As shown in Figure 3 (E), cells of high density are plated
into the center well. A central confluent monolayer is formed after a couple of hours (the specific
time to form the monolayer depends on the cell type and the culture environment). Then the
fence is removed and the dish is rinsed to remove any non-adherent cells. Cells in the dish are
cultured continuously for the assessment of cell migration.
The agarose assay is a method to study directed cell migration to one or more
chemoattractant sources. Small wells (or parallel channels) are cut into a layer of semi-solidified
agarose on a substrate. Cells and chemoattractant are loaded into different wells or channels.
Cells migrate towards the chemoattractant gradient in the semi-solidified layer or under the layer.
Cell migration is then assessed by fixing and staining. Researchers are able to control positioning,
timing and intensity of one or more chemoattractant signals with the agarose assay [25]. Figure 3
(F) shows a schematic view of the agarose assay.
The ECIS migration assay is a technique to quantitatively measure cell motion at
nanometer level [17]. In this technique, substrates used for cell culture are electrodes carrying
weak alternating current (AC) (usually in the frequency range from 1 to 40 kHz). A large change
in the measured electrical impedance of the electrodes is observed when cells attach and spread
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on the electrodes. When the impedance is tracked as a function of time, the fluctuations are the
direct measures of cell motion [17]. ECIS migration assay is often integrated with wound assay
to achieve automatic migration monitoring and quantification. Figure 3 (G) shows a microfluidic
device integrated with cellular impedance sensing for cell migration study.
The micropipette-based assay involves a fine glass tip with an internal diameter of 1 µm
formed by heating and pulling axially a glass capillary. The micropipette is filled with the
chemoattractant and the tip is positioned very close to cells. A radial gradient is formed at the
micropipette tip by either pneumatically ejecting the media of chemoattractant that is controlled
by a pneumatic pump. Alternatively, the media of chemoattractant can passively diffuse from the
micropipette tip into the surrounding media. Figure 3 (H) shows an electrophysiology
micropipette mounted in a micro controller positioned close to cells in a culture dish.
Though these models have been widely adopted to study cell migration, they had their
limitations. Cell migration in those models was confined in a two-dimensional (2D) substrate,
which normally lacked the stable chemical gradient to induce directed cell migration, and
mechanical simulation and interactions with other cells or ECM [26]. Most of these assays lack
the ability of real-time monitoring of cell migration. Limited information about cell velocities
and morphological changes during the migration can be extracted from these assays.
Their limitations can be overcome by microfluidic devices, which will be discussed in the
next chapter.
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Chapter 2. Microfluidic Gradient Device Based
Applications
2.1 Introduction to Microfluidics
Microfluidics is the science and technology of systems that process or manipulate small
(10-9 to 10-18 Liters) amounts of fluids, using channels with dimensions of tens to hundreds of
micrometers [ 27 ]. The advantages of microfluidics include small samples and reagents
consumption, low power consumption, low cost, small dead volume, high throughput, parallel
processing and short reaction time.
Emerged in the early 1980s, microfluidics has been used in the development of inkjet
printheads, DNA chips, lab-on-a-chip technology, micro-propulsion and micro-thermal
technologies. Key applications of microfluidics include continuous-flow microfluidics, dropletbased microfluidics, digital microfluidics, DNA chips (microarrays), molecular biology,
evolutionary biology, microbial behavior, cellular biophysics, optics, acoustic droplet ejection
and fuel cells [28].

2.2 Features of Microfluidic Devices
Laminar flow and large surface-area-to-volume ratio (SAV) are two important features of
microfluidic devices.
Laminar flow occurs when a fluid flows in parallel layers without disruption between the
layers, as shown in Figure 4 [29]. Flow patterns can be predicted with Reynolds Number (Re),
which is defined as the ratio of inertial forces to viscous forces, as shown in the following
8

equation, where

is the density of the fluid (kg/m3),

hydraulic diameter (m),

is the kinematic viscosity (m2/s),

is the

is the dynamic viscosity of the fluid (kg/(m·s)).

Figure 4. The optical micrograph that shows the laminar flow. Two different dyed aqueous
streams flow in parallel without turbulent mixing [30].
The flow is laminar when Re is smaller than 2300, while the flow is turbulent when Re is
larger than 4000. Because of the micro-scaled channels and low flow rates, most microfluidic
devices operate at the low Re [31], and flows in microfluidic devices are completely laminar.
Thus microfluidic devices are capable of keeping multi-stream laminar flows separated for long
travel distance and long time. Various microfluidic gradient generators have been designed based
on the laminar flow feature. One example is shown in Figure 5. Each of the three flows in the
inlet is separated into two branching channels and joined with another laminar flow to the next
level. The difference among ratios of each flow at each branching channels becomes smaller and
smaller as the flows go to next level. Finally a gradient is formed at the output channel where
each tree branching channel contributes to a different percentage of the input fluids.
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Figure 5. Perfusion based microfluidic gradient generator. (A) Design of the chamber, verified
by COMSOL modeling. The chamber was used to make counter gradients of two chemokines.
(B) Measurements of red fluorescent dyes in the channel. (C) Measurements of green fluorescent
dyes in the channel. (D) Comparison between modeled (dashed line) and measured profiles [32].
SAV is an important factor for the mass transfer over reactive surfaces in microﬂuidic
devices, which is central to explore and quantify biochemical reactions [33]. Compared to
macroscale devices that have a relative small SAV, microfluidic devices have larger SAV by
orders of magnitude, which make the surface phenomenon more dominant than volume factor.
Large SAV has the benefits of heat/gas transfer, reducing lateral transfer and reaction time
[34,35], cell attachment, growth, and proliferation. This makes capillary electrophoresis and high
throughput immunoassays more efficient in microchannels.
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2.3 Principles of Microfluidic Gradient Generators
Various biochemical signals dissolved in or bound to the extracellular space are in the
form of gradients [36]. The gradients can result in biological behaviors such as the directed cell
migration. Because of its capabilities of manipulating soluble biochemical gradients and
mimicking the cell microenvironment in vitro, microfluidic-based gradient devices have been
proven effective in studying biological processes such as directed cell migration and geometric
inﬂuence on cell survival [37].
Generally there are two types of microfluidic gradient devices according to the way of the
gradient generation: perfusion based and diffusion based. The chemical gradients generated by
perfusion-based devices utilize the properties of laminar flow, as shown previously in Figure 5.
Because the structures of microfluidic devices are in the micrometer scale, fluids in microfluidic
device are laminar flow, where streams of miscible fluids get mixed by diffusion across the
interfaces without turbulent mixing [1]. Perfusion-based gradient generator has the advantages of
generating precisely controlled stable gradients. However, the cells in such devices are exposed
to a continuous shear flow. Shear stresses introduced by the flow can influence the cell migration
and attachment [ 38,39 ] and cause adverse effects. Gradients generated by diffusion based
devices rely on the diffusive transport of signaling molecule across convection-free regions [40].
Shear stress is then avoided because no convection flow is involved in the establishment of the
gradient, and the cells’ migration will not be affected by shear stresses. The static gradient
environment provided by diffusion based devices are suitable for many types of cells in which
migration requires long period of time and cell adhesion is critical [41]. An example of diffusion
based gradient generator is shown in Figure 6. Table 1 compares the properties of the perfusion
based and diffusion based microfluidic gradient devices.
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Figure 6. Schematic view of the diffusion based microfluidic gradient device and its chemical
gradient profile. (A) A fluorescein solution with a known concentration was continuously flowed
in the chemo-effector channel and similarly the buffer solution was continuously flowed in the
buffer channel at a rate of 5 μLmin−1. (B) Fluorescent images of the center channel were
obtained and analyzed [42].
Table 1. Comparison between perfusion based microfluidic devices and diffusion based
microfluidic devices.
Properties

Perfusion Based Devices

Diffusion Based Devices

Gradient Establishment

Dynamic perfusion

Passive diffusion

Shear Stress

Yes

No

Gradient Duration

Long

Long

Gradient Stability

Stable

Stable

Reproducible

Yes

Yes

2.4 Biological Applications of Microfluidic Gradient Devices
Various platforms utilizing the microfluidic technologies have been developed to provide
biological experiments with precisely controlled spatial and temporal gradients of biomolecules.
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The perfusion based microfluidic gradient generator shown in Figure 5 is first developed
by Jeon et al [43]. By adjusting the flow rate and the concentrations of inlets solutions, different
shapes of profiles are achieved as shown in Figure 7. Additionally, multiple parallelly aligned
networks are developed to produce the saw tooth and the periodic gradient profiles [44].

Figure 7. Perfusion based microfluidic device and gradient profiles [40]. (A) Photograph
showing a premixing microchannel network generating gradients of green and red dyes. (B)–(D)
Gradients of Fluorescein isothiocyanate (FITC) observed at the outlet channel region at flow
rates of 1 mm/s, 10 mm/s, 100 mm/s respectively with dye delivered only to the center input
channel. (E)–(G) Linear and parabolic gradients of FITC generated with different concentrations
of three inlet solutions.
A universal gradient generator that can generate arbitrary monotonic gradients using flow
dividers is developed by Irimia et al [45]. The flow dividers controlled splitting and mixing of
flow streams by separating flows into defined volume ratios and controlling lateral transport of
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diffusing molecules, as shown in Figure 8. The position of the flow dividers can be determined
by mathematical calculation to generate user-defined concentration profiles including power,
exponential, error and cubic root functions [40].

Figure 8. Universal gradient generator. (A) Scanning electron micrograph that showed 8 levels of
flow dividers that controlled lateral transport of chemical species. (B) Fluorescence image that
showed the resulting FITC distribution. Scale bar is 500 mm.
An approach to switch gradient direction using multiple syringe pumps are developed by
Liu et al [46]. As shown in Figure 9 (A), four tubing inputs were connected to syringes filled
with the chemokine solution or the buffer solution alone. After filling the four segments of
tubing with the solutions in the syringes quickly, one pump is kept running at 0.5μl/min to
maintain a chemokine gradient that is high on the side of the channel of the top of Figure 9 (B).
After 20 min running, the first pump is stopped and the second pump is running to generate a
gradient with the high concentration on the side of the channel of the bottom of Figure 9 (C).
This approach is used to quantify the chemotaxis gradient and the effects of a change in the
direction of the gradient on the cell migration [46].
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A design that generated stable gradients of complex and arbitrary profiles along flow free
microfluidic channel is developed by Wu et al [47]. The device consists of a layer of porous
hydrogel between two poly (dimethylsiloxane) (PDMS) layers, as shown in Figure 10. The top
PDMS layer is embedded with two reservoirs for the chemoattractant solution and the buffer
solution. A gradient is formed across the middle hydrogel layer by diffusion. The bottom PDMS
layer is patterned with the user-defined microfluidic channels. The gradient profile of the
chemoattractant in the device is determined by the shape of microfluidic channels.

Figure 9. Perfusion based microfluidic gradient device that switches gradient direction using
multiple syringe pumps [46]. (A) Schematic view of a microfabricated switched gradient device
with dual two-syringe pumps. (B) Chemokine gradient formed by running Pump I. (C) Switched
chemokine gradient formed by stopping Pump I and running Pump II. The white arrows in (B)
and (C) indicate the flow direction in the main channel.
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Figure 10. Gradient generator that uses hydrogel and microfluidic channels [40]. (A) Schematic
diagram showing layers of gel and PDMS of the microfluidic device. (B) Various microfluidic
channels patterned onto the bottom layer of the device. (C) Calculated (red lines) and empirical
concentration profiles with various monotonic and complex shapes.
A microjets device that generates a dynamically controllable spatio-temporal
concentration gradient is developed by Keenan et al [48]. As shown in Figure 11, this platform
has an open reservoir that is positioned between a source manifold and a sink manifold. Each
compartment is connected through an array of microchannels (microjet arrays). The release of
chemicals into the gradient forming region (cell culture reservoir) is controlled by applying
pressure to each manifold. Dynamic regulations such as shifting or steepening concentration
gradients were achieved by adjusting the absolute and relative level of pressures [40].

Figure 11. The schematic view of the device showing the open architecture of the cell
culture/gradient chamber [48].
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Figure 12. Ladder chamber devices and their gradient profiles [50]. (A) Ladder chamber devices
with different microchannels. (B) Various gradient profiles are achieved by different
microchannels.
Saadi et al develops a two-compartment diffusion ladder chamber that generates stable
gradients across both 2D cell-culturing microchannels and 3D biological hydrogel [49]. This
platform is further expanded by Mosadegh et al by accomplishing generation of various gradient
profiles [50]. As shown in Figure 12 (A), this device consists of a source chamber and a sink
chamber that are connected via an array of microchannels. Balanced microchannels produce a
linear gradient profile, while unbalanced microchannels produce nonlinear gradient profile, as
shown in Figure 12 (B).

2.5 Advantages of Studying Cell Migration with Microfluidics
In vitro assays, which have been used for studying cell migration, mainly focus on using
conventional assays, including under-agarose assay, Boyden chambers, Dunn chamber, Zigmond
chamber and micropipette-based assay. However, the conventional assays have limited
capabilities of providing well-controlled chemical gradients or real-time monitoring cell
migration. These disadvantages can be overcome by microfluidic devices [51]. Advances in
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microfluidic chip technologies have enabled a variety of insights into biomedical sciences, such
as easily and tightly controlled biological conditions and dynamic fluidic environments,
mimicking essential aspects of cellular microenvironment, great flexibility in generating stable
and precisely controlled gradients, which will not have been possible with conventional
macroscale techniques. Microfluidic gradient devices have been used to study cell migration
recently [40,46]. Table 2 is a summary of the microfluidic gradient devices and conventional
assays.
Table 2. Comparisons between microfluidic gradient devices and conventional assays for
studying cell migration
Properties

Microfluidic Gradient Devices

Conventional Assays

Dynamic perfusion and static
Gradient control

Limited
diffusion
Yes and physiological relevant;

No / Limited physiological relevant;

individual cells; Multi-cell types

Large group of cells; single cell type

Yes

Very limited

Real-time monitoring 2D migration

Lack real-time observation; missing

and 3D invasion; repeatable

multiple parameters; repeatable

High throughput

Yes

No

Cost

Low

High

Control cell behavior
Capture critical
features of
microenvironments
Experimental results
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Chapter 3. Microfluidic Device Fabrication
Photolithography is the dominant technology for microfabrication. It is a process to
project the patterns of a photo mask or a chrome mask onto a photoresist thin film under the
exposure of ultraviolet (UV) light. The excessive photoresist can be washed off by the
photoresist developer to get the desired pattern transferred. It is capable of mass-producing
patterned structures in photoresist thin films with feature sizes as small as 100 nm by using deep
UV light and improved photoresists [52]. However, photolithography has its own limitations. It
is an expensive and time-consuming process. It cannot be applied for microfabrication based on
materials other than the photoresist, unless chromophore or photosensitizers are attached
accordingly. It has little control over the chemistry on the surface, thus does not work well for
3D microstructures, structures on nonplanar surfaces or patterns of specific chemical
functionalities on surfaces [52].

3.1 Polymer Based Soft Lithography
Polymer based soft lithography is a non-photolithographic set of microfabrication method
that generates patterned microstructures on polymers using patterned elastomer, molds or masks.
There are variety of polymers, including epoxy, polyurethane (PU), poly(methyl methacrylate)
(PMMA), poly(acrylonitrile-butadiene-styrene) (ABS), cellulose acetate (CA), polystyrene (PS),
polyethylene (PE), poly(vinyl chloride) (PVC) and PDMS. Various techniques have been
developed for soft lithography, such as microcontact printing (µCP), replica molding (REM),
microtransfer molding (µTM), micromolding in capillaries (MIMIC), solvent-assisted
micromolding (SAMIM), phase-shift photolithography, cast molding, embossing, and injection
molding [52]. Compared to photolithography, soft lithography is easy to change, suitable for
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working with large or nonplanar surface and low cost. The polymer used in soft lithography is
biocompatible and it has good chemical resistance and optical properties. In addition, because
polymers have been widely used in biomedical and electronic research, soft lithography can be
applied on applications in biotechnology and plastic electronics.

Figure 13. The fabrication processes for PDMS based microfluidic devices. Negative photoresist
(SU-8) is used for the demonstration. (A) The wafer is cleaned with acetone, methanol and
rinsed with DI water. (B) A layer of photoresist is spun-coated on the wafer. (C) A film mask
was brought to an intimate contact to the photoresist layer, then, they are exposed to a UV light
to transfer the pattern on the film mask to the photoresist layer. (D) Undesired photoresist is
washed off by photoresist developer to get the transferred pattern on the wafer. (E) A layer of
PDMS is poured on the wafer mold. The PDMS layer is cured in oven. (F) After punching holes,
the cured PDMS slab is bonded onto a glass substrate with oxygen plasma.
Figure 13 shows the standard fabrication process of PDMS based microfluidic devices
using soft lithography. The first step is to fabricate a master mold with standard photo
lithography (Figure 13 (A) to (D)). Briefly, after cleaning the wafer with acetone, methanol and
de-ionized (DI) water, a layer of photoresist is spun-coated on the wafer. The spinner used in this
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thesis is Laurel Technologies 400 Spinners, as shown in Figure 14. The thickness of the
photoresist depends on the requirements of specific devices. By setting appropriate RPM,
duration and acceleration speeds, different thicknesses can be achieved. The thickness of
photoresist determines the height of the channel when making PDMS devices. A photo mask is
brought to intimate contact with the photoresist on the wafer, which is then exposed to UV light.
The UV light exposure system used in this thesis is OAI LS30 UV flood exposure system, as
shown in Figure 15. For the negative photoresist, the area that is exposed under UV light stays
on the wafer after the development. Finally, the wafer is hard baked to totally cure the
photoresist.

Figure 14. Laurel technologies 400 spinner. It supports substrates from 10 mm to 6 inches. The
maximum speed is 8000 rpm. Multiple steps with different speed, acceleration and spinning time
can be programmed, saved and retrieved.
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Figure 15. OAI LS30 UV Flood Exposure System. It provides a uniform beam of UV light (365
nm) in a 5-inch diameter exposure area for photolithography processing. During exposure, the
system was set to constant intensity. After exposure, it was set to constant power.
The next step of the fabrication is a PDMS replica molding process using soft lithography
(Figure 13 (E) and (F)). The mixture of PDMS base solution and the curing agent (normally in a
ratio of 10:1 by weight) is first casted onto the master mold, then degassed under vacuum and
placed in an oven. When the PDMS mixture is cured, the PDMS slab is cut and peeled off from
the master mold. In this way the pattern is transferred from the master mold to the PDMS slab.
Then, the PDMS slab and a glass slide are treated with oxygen plasma (50 W, 100 mTorr) and
brought together to form a permanent irreversible bonding.

3.2 Chrome Mask Fabrication
In order to achieve a good alignment, a chrome mask was fabricated in cleanroom to
replace the film mask. The chrome mask was made from Telic chrome photomask blanks (Telic
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Company, Valencia, CA). It has a width of 4 inches, length of 4 inches and thickness of 0.06
inches. A layer with AZ 1500 (530 nm) was spun-coated on the thin chrome layer.
There were four patterns on each mask of the two photoresist layers. Four alignment
markers were in the center of the four device patterns. An opening that surrounded the four
alignment markers was added to the film mask for the second photoresist layer, as shown in
Figure 16. The opening was necessary so that the alignment markers on the first layer could be
seen during the alignment.

Figure 16. The film masks for the two layers wafer mold. For each film mask, only one pattern
and four alignment markers were shown in this figure. (A) Patterns on the first layer of the film
mask. (B) Patterns on the second layer of the film mask. The red square was the opening. (C)
The alignment markers on the two films were precisely aligned.
The film mask was brought to an intimate contact to the chrome photomask blank. In
order to transfer the patterns from the film mask to the photomask blank, they were exposed
under the UV light with the flood exposure system for 1.5 seconds with a constant UV intensity
of 20 mW/cm2. Then the photomask blank was developed in AZ 300 MIF developer for 30
seconds and rinsed with the DI water. The features of the second layer and mask aligner were
checked under a microscope. If the features were good, the photomask blank was submerged into
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Transene Chromium Etchants 1020 (Transene Company, Danvers, MA) for 3 minutes to etch off
the exposed chrome layer. The photomask blank was rinsed with 20% sulfuric acid during the
etching process. When the chrome layer was etched off, a glass layer would be seen at the
exposed part of the photomask blank. All the chrome on the pattern must be etched off to
produce a crystal clear pattern on the photomask. Any residual chrome could block the UV light
during the exposure, resulting in an unexposed photoresist region.

3.3 Mask Alignment
For wafer molds with more than one layer of photoresist, a mask aligner is needed to
have multiple layers accurately aligned. The mask aligner used in this thesis is Karl Suss MJB3
mask aligner, as shown in Figure 17.

Figure 17. Karl Suss MJB3 mask aligner. It is used for patterning multiple layers of
photosensitive polymer with UV light.
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The vacuum pump was turned on after the compressed air pressure of the two pressure
gauges reached 70-80 psi and 40-60 psi, respectively. The vacuum was required for holding the
sample and mask. When the display showed “rdy” (ready), the arc lamp was started and warmed
up for 15 minutes. The mask aligner was powered on when the LED of the arc lamp was 275
Watts (power supply). When the nitrogen pressures of three gauges (exposure, parallelity and
pressure/wafer) were 4 Bar, 2 Bar and 1 Bar, respectively, the mask aligner was ready to use.
Finally the microscope was turned on for alignment.

Figure 18. Intensity meter and holders [53]. (A) Karl Suss 1000 UV intensity meter and probe.
(B) Mask holder. (C) Sample holder and mask holder grooves on mask aligner. (D) Put probe on
sample holder and measure UV intensity.
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Before loading the sample into the sample holder for alignment and UV exposure, the
UV intensity should be measured and recorded. The Karl Suss 1000 UV intensity meter (Figure
18 (A)) was turned on and the probe was placed on the sample holder (Figure 18 (C)) for
intensity measurement (Figure 18 (D)). The exposure time was calculated based on the ratio of
the desired exposure dosage and the UV intensity. The exposure dosage was provided by the
manual of the photoresist (in this case, SU-8 2075) and depended on the thickness of the
photoresist on the wafer. After mounting the photomask on the mask holder (Figure 18 (B)), the
mask holder was flipped over and inserted into the mask holder grooves on top of the sample
holder. The wafer mold (with first layer of photoresist) was placed on sample holder. All vacuum
holes should be covered to have the wafer mold placed on the holder tightly during the alignment
and exposure.
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Chapter 4. Chronic Toxicity of Carbon Nanotubes and
Cell Model
4.1 Why Study Pleural Mesothelial Cells
The mesothelium is an extensive monolayer of mesothelial cells that lines the body’s
serous cavities and internal organs, such as lung, heart, abdomen and internal reproductive
organs, as shown in Figure 19 [54]. The primary functions of mesothelial cells include enzymes
regulation and production [55], antigen presentation [56], fluid and cell transportation [57],
wound healing [58], coagulation and fibrinolysis [59], tumor cell adhesion and growth [60].

Figure 19. Types of Mesothelium [61]. Pleural mesothelioma (red area) surrounds lungs and
lines chest cavity. Peritoneal mesothelioma (blue area) covers bulk of abdominal organs and
provides support and allowing movement. Pericardial mesothelioma (green area) lines the heart.
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Testicular mesothelioma surrounds male internal reproductive organs, mesothelioma of uterine
serosa covers female internal reproductive organs.
Malignant mesothelioma is a very aggressive tumor arises from mesothelial cells lining
the pleural, peritoneal and pericardial cavities. It has very low survival rates and there is no
effective therapy or consensus regarding treatment in spite of many years research [62]. Of all
malignant mesothelioma cases, pleural mesothelioma is the most common cancer that accounts
for about 70% of them [63]. Chronic exposure to asbestos is recognized as the major risk factor
and leading cause of malignant pleural mesothelioma, especially through the occupational
exposure to asbestos [64]. It is known that malignant pleural mesothelioma originates from
mesothelial cells’ aggressive spreading to the visceral pleural and beyond. Ultimately,
mesothelial cells will invade into the adjoining chest wall, lung, diaphragm and mediastinal
organs [62]. Because pleural mesothelial cells migration plays a crucial role in this process, it is
important to study the migration of human pleural mesothelial cells.

4.2 Potential Carcinogenicity of CNTs
Carbon nanotubes are allotropes of carbon with cylindrical structure, as shown in Figure
20 (A) and (B). Both single-walled CNT (SWCNT) and multi-walled CNT (MWCNT) are
macromolecules and featured with high tensile strengths, light weight, high aspect ratio and
stable thermal and chemical properties [65]. Their significantly large length-to-diameter ratio
makes them valuable for nanotechnology, electronics and optics. With extraordinary thermal
conductivity and mechanical and electrical properties, CNTs have the potential to be widely used
in drug delivery, high toughness material, solar cell, hydrogen storage, electrical circuits and
cable [66].
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Similar to asbestos, CNTs are high aspect ratio cylinders with diameters in the order of
nanometers and lengths in the order of micrometers [65,67] as shown in in Figure 20 (C) and (D).
Additionally, the mode of exposure of CNTs is similar to asbestos fibers, which is very light and
can become airborne and potentially reaches the lungs. This has raised a particular concern
regarding to the potential carcinogenicity of CNTs, especially in the pleural spaces, which are
key target tissues for asbestos-related diseases [68].

Figure 20. Carbon nanotube structures structure and scanning electron microscopy (SEM)
images [65]. (A) Structure of SWCNT, (B) Structure of MWCNT. (C) SEM micrograph of a
bundle of MWCNTs [69]. (D) SEM micrograph of synthetic tremolite asbestos [70].
Many in vivo studies have showed that CNTs are biopersistent and have low clearance
rate. CNTs can cause inflammation, fibrosis, and granuloma formation [71, 72, 73], and have the
potential to further induce mesothelioma [74]. Previous work studied the effect of long-term
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exposure to high aspect ratio CNTs on the aggressive behaviors of human pleural mesothelial
cells. Results indicated that SWCNTs and MWCNTs induced accelerated cell growth and
invasiveness, which are key cancer phenotypes that may contribute to mesothelioma
pathogenicity [68]. It is necessary to investigate the toxicity and carcinogenicity of CNTs
thoroughly to determine their safety for long-term exposure.

4.3 Studies on Mesothelial Cells Migration
Conventional assays and in vivo animal studies have been used to study the migration of
pleural mesothelial cells responding to the gradients of different chemical reagents. Nasreen et al.
demonstrated that pleural mesothelial cells could respond with haptotactic migration to a
gradient of transforming growth factor-β. The migration was performed in the polycarbonate
transwell. But only the number of migrated cells was evaluated [75]. Zhong et al. explored the
migration and proliferation of mesothelioma cells and how they were affected by matrix
metalloproteinase (MMP)-2, membrane-type1-MMP (MT1-MMP) and tissue inhibitor of MMP
(TIMP)-2. Again cell migration was evaluated by counting the number of migrated cells. No
information of migration speeds or morphological changes was provided [ 76]. Zolak et al.
showed that plural mesothelial cells were able to migrate into the lung and differentiate into
myofibroblasts with mice recombinant for green fluorescent protein driven by Wilms tumor-1
promoter. The migration was shown by the abnormal presence of (Wilms tumor-1) WT-1+ cells
within the parenchyma of an explanted lung from patient [ 77 ]. Nagai et al. showed that
transformed mesothelial cells (MeT5A) migrated in various directions to a distant site. The
migration velocities of most MeT5A cells were between 0.1 to 0.4 µm/min. The velocity was
calculated based on the original cell location from original position and its migrating time [78].
In terms of carcinogenicity of CNTs, Wang et al. showed that chronic exposure to SWCNT
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caused malignant transformation of human lung epithelial cells. The transformed cells exhibited
an apoptosis resistant phenotype characteristic of cancer [79]. In summary, limited information
about cells’ velocities and cell morphological changes during their migration were provided in
those studies, neither real-time monitoring of the cells were available.
In this thesis, a microfluidic device that generates a stable static gradient based on the
molecule diffusion to study the migration of the chronic SWCNTs exposed human pleural
mesothelial cells was presented. Different concentrations of FBS were used to establish the
gradient and compared to study the migration velocities and the number of migrated pleural
mesothelial cells. In addition, real-time imaging using the microfluidic device is able to provide
detail information regarding to cells’ morphological changes prior, during and after their
migration.
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Chapter 5. Microfluidic Device for Gradient
Generation and Cell Viability
In this thesis work, a perfusion based microfluidic gradient device, a pseudo-perfusion
based microfluidic gradient device and a static microfluidic gradient device were designed and
fabricated to generate the gradient and facilitate cell loading. Different matrix coating materials
(gelatin, collagen and fibronectin) and their concentrations were tried to facilitate cell attachment.
The perfusion based microfluidic gradient device had the shear stress issue. Cells were
dead after being exposed to the continuous flow for a few hours. The pseudo-perfusion based
microfluidic gradient device generated a linear gradient in a very narrow area, which was not
suitable for studying cell migration. The static microfluidic gradient device was not capable of
providing stable gradient. Cells in this device showed random movement during the experiment.
Finally a diffusion based microfluidic device with large reservoirs, chambers and
migration channels was proven successful for pleural mesothelial cells migration study. Cells
were healthy during the 24-hour experiment and directed migration was observed.

5.1 Perfusion Based Microfulidic Gradient Device
The perfusion based gradient device is shown in Figure 21. This device utilized
“Christmas tree” gradient network to form a perfusion based gradient in the observation channel.
Though excellent gradient can be generated, continuous shear stress introduced by perfusion
flow made it unsuitable for studying the pleural mesothelial cell migration. As shown in Figure
22, most cells in this perfusion based gradient device failed to adhere to the substrate after 5
hours of initial attachment, while cells in another static gradient device remained healthy. In
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addition, cells were loaded into a relative large channel (observation area), which made it
difficult to keep having similar number of cells at the interested region among different
experiments.

Figure 21. Perfusion based microfluidic gradient device. (A) Fabricated device. (B) Structure of
observation area. Numbers along the observation channel help to mark multiple positions.

Figure 22. Comparison of cell adhesion at the 5th hour between the perfusion based microfluidic
gradient device and static microfluidic gradient device. (A) Cells in the perfusion based gradient
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device at the 5th hour. Most cells failed to adhere to the substrate because of the shear stress
caused by the perfusion flow. (B) Cells in a static gradient device at the 5th hour. All cells were
alive and healthy. Some cells have turned into spindle-shape. The rest of cells turned into
spindle-shape at the 6th hour.

Figure 23. Pseudo-perfusion based microfluidic gradient device. (A) Fabricated device. (B)
Structure of the observation area. Small barriers between the side channels and middle channels
helped to confine cells in the middle channel.

5.2 Pseudo-perfusion Based Microfluidic Gradient Device
In order to overcome the shear stress effects on cells and generate a well-controlled stable
good gradient, a pseudo-perfusion based microfluidic gradient device was designed and
fabricated, as shown in Figure 23. First, all the channels were filled with sterilized DI water.
Then one inlet was connected to a syringe pump for loading perfusion media with the
chemoattractant, the other inlet was connected to another syringe pump for loading perfusion
media without the chemoattractant. Perfusion flows from Christmas tree gradient network were
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guided to two side channels in the observation area, cells were loaded into the middle channel, as
shown in Figure 23(B). Then a gradient perpendicular to the side channel was formed by
diffusion. Cells in the middle channel were able to sense this gradient and migrate. However, the
linear gradient (Figure 24) was formed within a narrow area for most of the time even though
very low flow rate was used in various experiments to generate a perfusion based gradient at the
two side channels. In order to reduce contaminations and media evaporation, PDMS plugs were
inserted into the cell chamber reservoirs during experiment.

Figure 24. The gradient profile of the pseudo-perfusion based microfluidic gradient device. (A)
Fluorescence image showing a stepped gradient. (B) The normalized intensity profile. This
profile showed that a linear gradient with a narrow width (approximately 100 µm) was formed
between the stepped gradient.

5.3 Diffusion Based Microfluidic Gradient Device
The diffusion based microfluidic gradient device was shown in Figure 25. It consisted of
two chambers for the gradient generation, a middle horizontal channel for cell loading and four
vertical migration channels. First, all the chambers and channels were filled with sterilized DI
water. Then the media of chemoattractant was initially loaded into one chamber, the
chemoattractant gradually diffused to the other chamber through the migration channels. In this
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way, the static gradient in the migration channels were formed. Overnight fluorescence imaging
with FITC dextran showed that gradient generated this way was not stable (Figure 26), which
resulted in random cell migration, as shown in Figure 27.

Figure 25. The static microfluidic gradient device. (A) Fabricated device. (B) Structure of the
observation area. The rectangular barriers along the vertical migration channels confined cells in
the horizontal middle channel for observation.
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Figure 26. FITC intensity gradient profiles at different 5th, 7th, 9th and 11th hour. The profiles
showed that the gradient was not stable.

Figure 27. Cell distribution in the static gradient device at the 6th (A) and 24th (B) hour. Cells
were alive and healthy during the experiment. However, random cell migration was observed
because of the non-stable gradient.
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5.4 Functional Device Design and Fabrication
A review of unsuccessful devices showed that the following requirements must be met
for a successful device to study pleural mesothelial cell migration:
1) No shear stress (gradient established mainly by diffusion);
2) Channels should be high enough to facilitate cell migration and hold enough media for
long-term (24 hours) experiment and imaging;
3) An appropriate coating protein with an appropriate concentration on the glass substrate is
required to facilitate cell attachment.

Figure 28. Microfluidic gradient device. (A) Two devices fabricated and bonded on one glass
slide. One is for the control group test, the other is for the CNTs treated group of cells. (B) Image
shows the cell receiving chamber, the migration channels, and the cell seeding chamber,
respectively. (C) Schematic view of the cross section of the device shows different heights of the
cell chambers and migration channels.
Based on those requirements, another microfluidic device was developed for the stable
static gradient generation and live cell imaging. The device consisted of a cell seeding chamber,
five migration channels and a cell receiving chamber as shown Figure 28 (A). Two devices were
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fabricated on a glass slide together. For each experiment with the same FBS concentration
gradient, one device was used for observing SWCNTs treated cells, and another device was used
for the control group, in which the cells were not treated with SWCNTs. Four reservoirs with a
diameter of 6 mm were punched for cell and solution loading. The chambers had a width of 600
µm and a height of 160 µm. The migration channels had a dimension of 400 µm in length, 80 µm
in width, and 16 µm in height. The cell seeding/receiving chambers were much deeper than the
cell migration channels for better control the gradient. The volume of each chamber was 0.52 µL
and the volume of each reservoir was 4.5 µL. The total volume of this device was approximately
19 µL, which was enough for a 24-hour experiment.
Standard photolithography and soft lithography were used for the master molds
fabrication. PDMS soft lithography was used for device fabrication. The bottom migration
channel was first fabricated using SU-8 2025 (MicroChem) to get shallow cell seeding and
receiving chambers. The thickness of the bottom layer was 16 µm. SU-8 2075 (MicroChem) was
then spun-coated over the bottom thin layer to form a second layer. After alignment, the top layer
was exposed under the UV light, developed and hard baked. The heights of mold at the cell
seeding and receiving regions were 160 µm. Silicone elastomer base (Slygard 184, Dow
Chemical) was mixed with curing agent (Slygard 184, Dow Chemical) at a ratio of 10:1 and
casted onto the master mold to obtain a 3 mm thick of PDMS layer. After curing the device in an
oven at 60°C for three hours, the thick PDMS slab was cut and peeled off from the mold. Device
reservoirs for cell and media loading were punched using a 6 mm diameter puncher. Two
replicated PDMS devices and a glass slide were treated with oxygen plasma (50 W, 100 mTorr)
for 20 seconds, and then they were brought together to form a permanent irreversible bonding.
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Before the cell experiment, the microfluidic devices were filled with DI water and UV sterilized
for eight hours inside a biosafety hood.

5.5 Gradient Characterization
The concentration of the FBS gradient was visualized and quantified with FITC-albumin
(Sigma-Aldrich, Saint Louis, MO). Similar to the experimental condition, 10% FITC-albumin
solution was loaded into the receiving reservoir to confirm and characterize the gradient
generated in migration channels. Fluorescence images were taken every 15 minutes for 24 hours
using an inverted microscope (Nikon Eclipse Ti, Japan). The fluorescence intensities in the
region of the migration channels were recorded.

Figure 29. (A) Fluorescence image shows the gradient across one migration channel. Dashed
white lines indicated the boundary of migration channel. Scale bar is 80 µm. (B) The time course
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of FITC-albumin gradient across the width of the channel. The normalized fluorescence
intensities along the migration channel at different time were compared, showing a stable linear
gradient through the migration channel.
As shown in the Figure 29, the gradient profile showed that a stable gradient was
established after 4 hours and remained linear till the end of the experiment. Because of the
reduced height in the migration channels, the fluidic resistance in these channels is high and
further minimized the convective flow through the channels [4]. The gradient in the migration
channels was generated mainly by diffusion [80].
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Chapter 6. Experiment Methods
6.1 Cell Culture and Chronic SWCNTs Exposure
Human pleural mesothelial MeT5A cells were acquired from American Type Culture
Collection (Manassas, VA) and maintained in M199 medium (Life Technologies, Grand Island,
NY) with 5% FBS, 2 mM L-glutamine, 100 U/mL penicillin/streptomycin, 1 µg/mL EGF and 50
µg/mL hydrocortisone. Cell cultures were performed in a humidified atmosphere of 5% CO 2 at
37°C. SWCNTs, synthesized using high-pressure carbon monoxide disproportionate process
(HiPCO), were obtained from Carbon Nanotechnology (CNI, Houston, TX). Elemental analysis
of the supplied SWCNTs by nitric acid dissolution and inductively coupled plasma-atomic
emission spectrometry (ICP-AES, NMAM #7300) showed that SWCNTs were 99% elemental
carbon and contained less than 1% w/w of contaminants. Diameter and length distribution of
dispersed SWCNT measured by field emission scanning electron microscopy (FESEM, model S4800; Hitachi, Tokyo, Japan) demonstrated 1.42 µm mean length and 0.38 µm mean width,
respectively. Particles possessed surface areas between 400-1040 m2/g.
The cells were continuously exposed to a sub-cytotoxic concentration (0.02 µg/cm2) of
SWCNTs or vehicle for 4 months following the method previously described [81]. Briefly, 0.1
mg/mL stocks of SWCNTs in phosphate buffer saline (PBS) containing 150 μg/mL Survanta®
(Abbott Laboratories, Abbott Park, IL) were sonicated and diluted in media (0.1 μg/mL) prior to
cell exposure. Cells were exposed to the dispersed particles every 3 days following a PBS wash
and passaged once per week to initial seeding densities.
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6.2 Long Term Imaging
After sterilization, two microfluidic devices were coated with 50 µg/mL fibronectin for
one hour at room temperature to enhance the cell attachment. After that, the fibronectin solution
was replaced by serum free M199 medium and the devices were placed inside an incubator for
warming up. Then, the chronic SWCNTs exposed human mesothelial cells (1×106 cells/mL)
were loaded into the seeding chamber in one device, and non-SWCNTs treated human
mesothelial cells as control group were loaded into the other device. Both devices were kept in
the incubator at 37 °C with 5% CO2 for 2 hours for cell attachment. Finally, the devices were
placed onto the microscope incubation stage for imaging.

Figure 30. Real-time imaging system. Devices were placed on the stage in the cage incubation
system. The movement of the stage was controlled by the controller equipped with the Nikon
NIS Element software. Cells and device structures were shown and recorded in the monitor.
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A Nikon Eclipse Ti inverted fluorescence microscope (Japan) equipped with an OKOLab
(Italy) Cage incubation system was used for the long-term and real-time imaging. The
microscope is fully automated for imaging multiple positions in sequence and equipped with
long working distance objectives and rapidly acquires high-resolution phase contrast and
fluorescent real-time images. The cage incubator system includes an enclosure, a temperaturecontrol module, a CO2 and humidity modules, and a stage insert chamber. For each experiment,
three positions, including one over the cell seeding chamber, one over the migration channel, and
one over the cell receiving chamber, were imaged and tracked for each migration channel, and a
total of 15 positions were recorded for each device. At each position, the bright field images
were taken every 15 minutes for over 24 hours. The whole set up image is shown in Figure 30.

Figure 31. Devices in a sealed Petri dish. The Petri dish will be fixed on the stage for imaging.
Two devices bonded on one glass slide were put into a Petri dish and fixed with sterilized
tape. A sterilized wet tissue was placed next to the devices to keep the environment inside the
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Petri dish humid. Two small holes were punched on the side wall of the Petri dish as inlets of the
temperature sensor and source of filtered CO2 and air. Then the Petri dish was sealed with
sterilized parafilm wrap (Parafilm, Neenah, WI), as shown in Figure 31. The Petri dish was
placed on a holder in the stage of the cage incubator system and fixed with sterilized tape.

6.3 Cell Movement Analysis
ImageJ was used to track and analyze the cell movement. The MeT5A cells, which
migrated the distance over two cell diameters (about 20 μm) from their original positions and
kept moving along the gradient, were counted as exhibiting responses to the FBS gradient. The
cells that remained within a 20 μm radius of their original positions were excluded from the
analysis, as were cells that stopped or detached from the substrate. For each cell that meets this
requirement, the starting position, ending position, starting time and ending time were recorded.
Cell displacement was the difference between the starting position and ending position. Cell
migration velocity was calculated by dividing displacement by the time. Then the average
velocity and standard error for all cells in one experiment were calculated.
For number of migrated cells, large images were taken before and after each experiment
using image stitching technique supported by the Nikon NIS Element software. Basically, four
images at 10X magnification at different positions were taken before (when cells were attached
and media with 10% FBS was loaded into receiving chamber) and after each experiment (when
the 24-hour experiment was ended). After image stitching, the large image covered the cell
seeding chamber, cell receiving chamber and migration channels. The number of cells in the area
of interests in the corresponding large images was counted. By finding the difference of cell
numbers between prior-experiment and post-experiment images, the number of migrated cells
were obtained for each experiment.
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The results for cell velocity and number of migrated cells were evaluated by the twotailed t-test and single factor analysis of variance (ANOVA). Each experiment was repeated for
three times.
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Chapter 7. Results and Discussion
7.1 Cell Morphological Changes
Initially after the cells were loaded inside the devices, cells were kept in an incubator. It
took 2~3 hours for the cells to adhere on the fibronectin coated glass substrate. Most of the cells
were flattened shape after adhesion as shown in Figure 32 (A) and (E). Prior to migration,
elongated and spindle shaped cells were clearly observed as shown in Figure 32 (B) and (F). The
result indicated that the cells needed to undergo morphological transition from the initial
flattened shape in initial adhesion to spindle shape. The morphological transition was consistent
with the conclusion of Lauffenburger [8] that cells must acquire spatial asymmetry by
polarization prior to migration. This transition began at approximately 6 hours after the initial
time point (Figure 32 (A)). The morphological transition observed in our experiment was similar
to the mesothelial cells’ morphological change observed in vivo [78].
During the subsequent migration, the cells kept their elongated and spindle shapes and
moved through the channels along the gradient direction (Figure 32 (C) and (G)). Some cells
showed considerably elongated shapes during their migration. After the cells migrated through
the channel, the cells showed the random migration because of the uniform concentration of FBS
in the receiving chamber. However, the cells (Figure 32 (D) and (H)) still kept their morphology
similar to that shown in Figure 32 (B). Additionally, both the control cells and SWCNTs treated
cells exhibited the similar migratory behaviors in their morphology as shown in Figure 32.
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Figure 32. Cell morphologies at adhesion, prior to migration, during migration and after
migration. A to D are control cells, E to H are SWCNTs treated cells. Most of the cells are
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flattened shape after adhesion, then they gradually turn to spindle shape prior to migration. (A)
Control cell morphology after the initial adhesion. (B) Control cell morphology prior to their
migration (~ 6 hours after adhesion). (C) Control cell morphology during migration. (D) Control
cell morphology after migration. (E) SWCNTs treated cell morphology after initial adhesion. (F)
SWCNTs treated cell morphology prior to migration. (G) SWCNTs treated cell during migration.
(H) SWCNTs treated cell after migration.
Conventional assays normally lack the ability to provide direct evidence to show the
morphological changes during cell migration although it has been suggested that mesothelial
cells need to undergo morphological transitions in response to inflammation or mesothelial
injury [82, 83, 84]. Our microfluidic gradient device provides the technique and an experimental
approach with direct observation of the dynamics of the morphological transition in mesothelial
cell behavior as well as other types of cells.

7.2 Migration Velocity
Different concentrations of FBS, varying from 5% - 20%, were used to compare
migratory behaviors between the SWCNTs treated and untreated MeT5A cells. FBS was used as
the chemoattractant reagent because it contains a mixture of chemokines varying in size from
430 Da to 13 kDa and is widely used as the chemoattractant in Boyden chamber (Transwell cell
migration assay) [85]. Previous work studied the effect of long-term exposure to high aspect
ratio CNTs on the aggressive behaviors of human pleural mesothelial cells (MeT5A). Results
indicated that SWCNTs induced accelerated cell growth and invasiveness [68].
As shown in Figure 33, cell velocities under different FBS concentration gradients for
both control and treated cell groups were compared. In this thesis, the average velocity of
MeT5A cells’ movement without the FBS gradient (0% FBS) was slower compared to the
average velocity of the cells in the presence of the FBS gradient. With 5% FBS concentration
gradient, faster cell movement was observed but no significant different in velocities were found
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between control cells and SWCNTs treated cells (control 21.38±1.24 µm/hour, treated
22.22±1.27 µm/hour, p=0.64). Chronic SWCNTs exposed MeT5A cells demonstrated higher
velocities under the 10% FBS concentration compared to the control cells (control 9.74±1.66
µm/hour, treated 22.35±1.65 µm/hour, p=0.04). At 15% and 20% FBS concentration gradients,
the velocity of chronic SWCNTs exposed MeT5A cells movement was decreased compared to 5%
and 10% FBS concentration gradients (5%: 22.22±1.27 µm/hour, 10%: 22.35±1.65 µm/hour,
15%: 19.89±1.20 µm/hour, and 20%: 13.03±0.96 µm/hour). Compared to other FBS
concentration gradients, significantly slower movement of SWCNT-exposed cells under 20%
FBS concentration was observed (p=2.88×10-8, 1.29×10-6, 1.12×10-5 when compared to 5%, 10%
and 15% FBS experiments, respectively). Additionally, chronic SWCNT-exposed cells
demonstrated slower velocities than control cells under 15% and 20% FBS concentration
gradients.

Figure 33. Average velocities of cell migration under different FBS concentration gradient for
both control and treated cell groups with standard error bars. P values are marked between same
group and different groups.
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The velocities observed in this thesis are consistent with the speed observed and reported
in in vivo animal experiment previously, which stated that the velocities of most migrated
mesothelial cells were between 6 µm/hour to 24 µm/hour with an average velocity of 14
µm/hour [78].

7.3 Number of Migrated Cells
Data for the number of migrated cells was extracted and compared for each FBS
concentration. Four images covering the whole device were taken at the beginning and the end of
each experiment, respectively. Then the four images were combined into one large image using
image stitching technique supported by the Nikon NIS Element software, in which cell numbers
and distribution could be clearly identified and counted. Number of migrated cells were analyzed
and compared based on large images. Difference in cell distribution was clearly shown in Figure
34, where more cells were observed in the migration channels and the cell receiving chamber at
the end of the experiment.
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Figure 34. Large images showing cell distributions at the beginning and the end of the
experiment. (A) At the beginning of the experiment, most cells were in the cell seeding chamber.
A small portion of cells were in the migration channels. (B) After 24 hours, more cells were
observed in the migration channels. Some cells have migrated through the migration channels to
the cell receiving chamber.

Figure 35. Average number of migrated cells under different FBS concentration gradients for
both control and treated cell groups.
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Compared to the non-FBS condition, increased number of the migrated cells in the
presence of FBS was observed in both SWCNT-exposed and control cells. For SWCNT-exposed
cells, the number of migrated cells was increased with increasing FBS concentration of gradients.
For control cells, the maximum number of migrated cells was observed in the experiment of 5%
FBS concentration gradient, and then the number of migration cells gradually decreased when
FBS concentration of gradients at 10% and 15% (Figure 35). Compared between the SWCNTexposed cells and the control cells, no significant difference in the number of migrated cells were
found in the experiment with 5% FBS concentration of gradient (control: 71.33, SWCNT-treated:
62). More SWCNTs chronic exposed MeT5A cells migrated under the 10% and 15% FBS
concentration of gradients, respectively (10% FBS: control 53.33, SWCNTs-exposed 75; 15%
FBS: control 47.67, SWCNTs-exposed: 92).
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Chapter 8. Conclusions and Future Work
8.1 Conclusion
Pleural mesothelial cells migration plays a crucial role in the process of malignant pleural
mesothelioma, which is most common cancer of all malignant mesothelioma cases. High aspect
ratio CNTs have the potential to contribute to mesothelioma pathogenicity. In this thesis, a
microfluidic gradient device for studying the migration of mesothelial cells and the effects of
chronic exposure to SWCNTs on their migration was designed and fabricated. Different
concentrations of FBS (5%, 10%, 15% and 20%) were tested as chemoattractant to evaluate the
motility and morphology of pleural mesothelial cells. The average velocity of chronic SWCNTs
exposed cells was faster with the presence of FBS compared to non-FBS (0% FBS). The velocity
decreased as the FBS concentration increased from 5% to 20%. The velocity for chronic
SWCNTs treated cells was faster than control group cells with 5% and 10% FBS. It was slower
at 15% and 20% FBS concentration gradients. Increased number of migrated cells in the
presence of FBS was observed in both SWCNT treated and control cells compared to no FBS
condition. For chronic SWCNT treated cells, the number of migrated cells was increased with
increasing FBS concentration of gradients. For control cells, the maximum number of migrated
cells was observed in the experiment of 5% FBS concentration gradient. The number of
migration cells decreased when FBS concentration of gradients at 10% and 15%.
The results showed that chronic exposure of human pleural mesothelial cells to SWCNTs
induced cell transformation with cancer-like properties such as rapid growth and increased cell
migration with the presence of 10% FBS as the chemoattractant.
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The microfluidic approach demonstrated in this thesis is able to provide real-time
observation of the dynamic behaviors of the pleural mesothelial cells in the responses to
chemical gradients as well as quantify their migration velocities under different gradient
conditions. Large reservoirs in the device were capable of providing enough media for long-term
experiment and imaging. The device’s simple structure was convenient for device fabrication
and cell/media loading. The presented microfluidic gradient device will be applicable to study
other types of adhesion cells in which gradient generated by non-shear flow condition may be
more preferable.

8.2 Future Work
More experiments regarding cell migration velocity and number of migrated cells need to
be done with the microfluidic device that can provide different gradient steepness. New patterns
that can facilitate cell loading and cell attachment need to be designed and tested. Cell
morphological changes regarding protrusive force and contractile force need to be further
analyzed.
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